Literature DB >> 4544120

Missing indicator function of growth hormone and luteinizing hormone blood levels for dopamine and serotonin concentration in the human brain.

O Benkert, G Laakmann, A Souvatzoglou, K von Werder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4544120     DOI: 10.1007/bf01242751

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  20 in total

1.  SEROTONIN SUPPRESSION OF LUTEINIZATION IN GONADOTROPHIN-TREATED, IMMATURE RATS.

Authors:  W K O'STEEN
Journal:  Endocrinology       Date:  1964-06       Impact factor: 4.736

2.  Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

3.  Influence of brain neurohumors injected into the lateral ventricle of the rat on growth hormone release.

Authors:  E E Müller; P Dal Pra; A Pecile
Journal:  Endocrinology       Date:  1968-10       Impact factor: 4.736

4.  Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.

Authors:  O Benkert; H Gluba; N Matussek
Journal:  Neuropharmacology       Date:  1973-03       Impact factor: 5.250

5.  Effects of manipulation of brain monoamines on pituitary function. Catecholamines and control of growth hormone secretion.

Authors:  E E Müller
Journal:  Neurosci Res Program Bull       Date:  1971-03

6.  The effect of L-DOPA on brain catecholamines and motility in rats.

Authors:  J Maj; M Grabowska; E Mogilnicka
Journal:  Psychopharmacologia       Date:  1971

7.  A semiautomatic method for immunoassay of insulin and human growth hormone.

Authors:  P Bottermann; R Ermler; J Henner
Journal:  Horm Metab Res       Date:  1971-01       Impact factor: 2.936

8.  Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.

Authors:  L L Butcher; J Engel
Journal:  Brain Res       Date:  1969-09       Impact factor: 3.252

9.  Repetitive luteinizing hormone elevations in serum of normal men.

Authors:  H R Nankin; P Troen
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

10.  Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.

Authors:  M J Perlow; J F Sassin; R Boyar; L Hellman; E D Weitzman
Journal:  Dis Nerv Syst       Date:  1972-12
View more
  2 in total

1.  Neuroendocrine effects of quipazine in man in health state or with neurological disorders.

Authors:  E A Parati; P Zanardi; D Cocchi; T Caraceni; E E Müller
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

2.  The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.

Authors:  G Gründer; H Wetzel; A Hillert; E Jochum; C Hiemke; O Benkert
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.